Skip to main content
VCbacked
Log inGet Started

Bardy Diagnostics

Seattle, United States

Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device .

$10.5M raised
May 2025
Venture - Series Unknown
Health CareHealth DiagnosticsMedicalMedical Device

Top Investors

SV Health InvestorsHealthQuest CapitalLumira VenturesAphelion CapitalHealth Enterprise Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bardy Diagnostics

How much funding has Bardy Diagnostics raised?
Bardy Diagnostics has raised $10.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Who are Bardy Diagnostics's investors?
Bardy Diagnostics's investors include SV Health Investors, HealthQuest Capital, Lumira Ventures, Aphelion Capital, Health Enterprise Partners.
Where is Bardy Diagnostics headquartered?
Bardy Diagnostics is headquartered in Seattle, United States.
What does Bardy Diagnostics do?
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device .
What stage is Bardy Diagnostics at?
Bardy Diagnostics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Bardy Diagnostics — Funding & Investors." VCBacked, May 8, 2025, https://www.vcbacked.co/company/bardy-diagnostics. Accessed June 19, 2026.
APA
VCBacked. (2025). Bardy Diagnostics — Funding & Investors. Retrieved June 19, 2026, from https://www.vcbacked.co/company/bardy-diagnostics
Wikipedia (cite web)
{{cite web |title=Bardy Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/bardy-diagnostics |website=VCBacked |access-date=June 19, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K